Please assess the completion status of the following clinical trial:

Trial Title: Moxibustion for Primary Dysmenorrhea

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: EARLY_PHASE1
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Clinical diagnosis of Guidelines of Primary dysmenorrhea clinical by the Society of Obstetricians and Gynaecologists of Canada~* Menstrual cycle is regular (28±7) days~* Syndrome differentiation of Traditional Chinese Medicine: Congealing cold-damp and Qi-stagnation and blood stasis~* Mean value of ≥40mm during last 3 months~* Informed consent form must be signed by patient or lineal relative~Exclusion Criteria:~* Patients with secondary dysmenorrhea, which is caused by endometriosis, pelvic inflammation, myoma of uterus and so on~* Patients who are unconscious and psychotic~* Patients with serious primary illness or diseases of cardiovascular, liver, renal, gastrointestinal, hematological systems and so on~* Patients take prostaglandin synthetase inhibitors (PGSI) 2 weeks before inclusion~* Pregnant women or women in lactation

- Gender: FEMALE
- Minimum Age: 13 Years
- Maximum Age: 35 Years
- Healthy Volunteers: f

Study Arms:
- Moxibustion treatment group (Type: EXPERIMENTAL): Apply traditional acupuncture to prevent the dysmenorrhea according to traditional Chinese medicine theory
- Medicine control group (Type: ACTIVE_COMPARATOR): Ibuprofen Sustained Release Capsules will be penetrated for dysmenorrhea

Based on this trial design, predict the completion outcome and termination type (if applicable).